---
title: ES-2 Orthotopic Model - TD2 Precision Oncology
description: ES-2 is an ovarian cancer cell line widely used for studying ovarian cancer and evaluating therapeutic interventions.
image: https://td2inc.com/hubfs/Assets/GraphsFigures/es-2.png
---

×

 

[![td2-logo](https://td2inc.com/hubfs/td2-logo.png "td2-logo")](https://td2inc.com/?hsLang=en)

![Search Site](https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png)

[![td2-logo](https://td2inc.com/hubfs/td2-logo.png "td2-logo")](https://td2inc.com/?hsLang=en)

![Search Site](https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png)

# ES-2 Orthotopic Model

**Synonyms:** –

ES-2 is a well-established human ovarian cancer cell line used as a model for studying ovarian cancer. It retains key features of ovarian cancer, including epithelial morphology, proliferation, and resistance to therapies. ES-2 serves as a valuable tool for investigating ovarian cancer biology, evaluating therapeutic approaches, and testing potential anti-cancer agents. Researchers utilize this cell line to explore ovarian cancer pathogenesis, identify therapeutic targets, and develop novel treatment strategies.

## Model Details

**Cancer Type:** Ovarian Cancer  
**Model Name:** ES-2  
**Mouse Strain:** Nu/Nu  
**Treatment Data Available:** N/A

## ES-2 Survival

![ES-2 Orthotopic Model](https://td2inc.com/hubfs/Assets/GraphsFigures/es-2.png)

Survival of IP Disseminated ES-2 in Nu/Nu mice (n=10)

### Request Additional Syngeneic Model Data

## CONTACT US

## Get Started.

Have questions about how TD2 can assist with your regulatory needs? Reach out to our expert staff today to get started.

[Get Started Now](https://td2inc.com/contact-us/?hsLang=en)

[![td2-logo-footer](https://td2inc.com/hs-fs/hubfs/td2-logo.png?width=160&name=td2-logo.png)](https://td2inc.com/?hsLang=en)

Office  
13208 E. Shea Blvd,   
Suite 100   
Scottsdale, AZ 85259

Phone  
(602) 358-8300

Connect with us

- <https://www.linkedin.com/company/translational-drug-development/>
- <https://twitter.com/TD2_Oncology>

![td2-logo-footer](https://td2inc.com/hs-fs/hubfs/Assets/Logo/acclac-logo.png?width=139&name=acclac-logo.png)

© 2026 Translational Drug Development. All Rights Reserved. [Terms and Conditions](https://td2inc.com/terms-and-conditions?hsLang=en) | [Privacy Policy](https://td2inc.com/privacy-policy?hsLang=en)